• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

Medical News Interviews

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Tagged: cancer

  • Orteronel shows no survival advantage in metastatic castration-resistant prostate cancer: phase III randomized study finds 0
    • in Oncology · Video
    • — 6 Feb, 2014

    Orteronel shows no survival advantage in metastatic castration-resistant prostate cancer: phase III randomized study finds

    SAN FRANCISCO—Orteronel — a non-steroidal selective inhibitor of 17,20-lyase — did not achieve a significant improvement in overall survival in 1099 patients randomised to treatment with this “abiraterone-like” agent in comparison with placebo — though radiographic progression-free survival was improved. …

    Read more
    Idelalisib: new targeted therapy improves outlook for patients with chronic lymphocytic leukaemia 0
    • in Oncology
    • — 24 Jan, 2014

    Idelalisib: new targeted therapy improves outlook for patients with chronic lymphocytic leukaemia

    NEW ORLEANS—A new oral tyrosine kinase inhibitor drug — idelalisib — has proved effective — and to have low toxicity — in patients with chronic lymphocytic leukaemia (CLL). Richard Furman MD from Weill Cornell Medical College in New York announced …

    Read more
  • First effective treatment for “orphan disease’: Anti I/L 6 antibody brings remissions in Multicentric Castleman's Disease 0
    • in Oncology · Video
    • — 21 Jan, 2014

    First effective treatment for “orphan disease’: Anti I/L 6 antibody brings remissions in Multicentric Castleman’s Disease

    The rare, fatal lympho-proliferative condition: Multicentric Castleman’s Disease — MCD — could soon be treatable following findings announced at the American Society of Hematology annual meeting in New Orleans. Dr. Raymond S Wong MD, PhD — who is a hematology …

    Read more
    Chimeric antigen receptor T-cell therapy: high remission rate in relapsed, refractory acute lymphoblastic leukemia 0
    • in Oncology · Video
    • — 19 Dec, 2013

    Chimeric antigen receptor T-cell therapy: high remission rate in relapsed, refractory acute lymphoblastic leukemia

    NEW ORLEANS—High remission rates with extended survival are being achieved in patients who had failed all other therapies — including allogeneic stem cell transplantation — for their acute lymphoblastic leukemia and otherwise had very short life expectancies. Stephan A Grupp, …

    Read more
  • Healthcare Delivery And Spending: Big Impact On Cancer Survival 0
    • in Public Health
    • — 3 Sep, 2009

    Healthcare Delivery And Spending: Big Impact On Cancer Survival

    LONDON—Inequalities in cancer care delivery and overall spending have had a big impact on cancer survival rates in Europe, according to Michel Coleman, Professor of Epidemiology and Vital Statistics at the London School of Hygiene and Tropical Medicine. …

    Read more
    Global Handwashing Day!; Sex and Health; More Prisoners: More TB; How to Survive Cancer 0
    • in Public Health
    • — 15 Oct, 2008

    Global Handwashing Day!; Sex and Health; More Prisoners: More TB; How to Survive Cancer

    Val Curtis
    Val Curtis

    Global Handwashing Day is October 15th, 2008: an opportunity to remind everybody that millions of lives, especially children’s lives, can be saved by avoiding diarrhoea and other diseases spread when mothers, fathers, family members and friends fail to
    …
    Read more
  • Audio Journal of Oncology Volume 16 Number 11 0
    • in Oncology
    • — 3 Jun, 2008

    Audio Journal of Oncology Volume 16 Number 11

    Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan)

    Sarah Maxwell and Peter Goodwin report from: American Society of Clinical Oncology Annual Meeting, May 30-June 3, 2008, Chicago

    Michael Gnant
    Michael Gnant

    In this edition:

    1. Zoledronic …

    Read more
    Audio Journal of Oncology Volume 16 Number 10 0
    • in Oncology
    • — 25 May, 2008

    Audio Journal of Oncology Volume 16 Number 10

    Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan)
    Commenting Expert: Michael Untch, HELIOS Klinikum, Berlin

    In this edition Peter Goodwin and Sara Freeman report from:
    European Breast Cancer Conference, Berlin, April 15-19, 2008;
    Chemotherapy …

    Read more
  • Audio Journal of Oncology Volume 16 Number 9 0
    • in Oncology
    • — 26 Apr, 2008

    Audio Journal of Oncology Volume 16 Number 9

    Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan)
    Commenting Expert: Emiel Rutgers, Netherlands Cancer Institute, Amsterdam

    Angel Rodriguez
    Angel Rodriguez

    In this edition:

    1. Lapatinib: Targets Breast Cancer Stem Cells?

    Angel Rodriguez, Baylor College, Houston…

    Read more
    Audio Journal of Oncology Volume 16 Number 8 0
    • in Oncology
    • — 15 Apr, 2008

    Audio Journal of Oncology Volume 16 Number 8

    Scientific Editors: George Canellos, Pat Price, Gordon McVie, Gianni Bonadonna

    In this edition:

    Bevacizumab and Survival in Metastatic Breast Cancer

    Source: N Engl J Med 357:26
    George Canellos, Dana-Farber Cancer Institute, Boston
    Progresson-free survival, but not overall survival, was …

    Read more
  • Risks From Stopping Cancer Trials Early! 0
    • in London School of Hygiene & Tropical Medicine
    • — 9 Apr, 2008

    Risks From Stopping Cancer Trials Early!

    Giovanni Apolone
    Giovanni Apolone

    In this edition of Audio News, presented by Peter Goodwin, Giovanni Apolone (Mario Negri Institute, Milan) and Stuart Pocock (London School of Hygiene and Tropical Medicine), talk about:

    Risks From Stopping Cancer Trials Early!
    – A report from

    …
    Read more
    Debate: Adjuvant Chemotherapy Should Be Standard in Stage I Non-Small Cell Lung Cancer 0
    • in General Medicine
    • — 21 Mar, 2008

    Debate: Adjuvant Chemotherapy Should Be Standard in Stage I Non-Small Cell Lung Cancer

    Giorgio Scagliotti
    Giorgio Scagliotti
    Robert Pirker
    Robert Pirker

    GIORGIO SCAGLIOTTI, University of Turin
    ROBERT PIRKER, Medical University of Vienna
    A heated debate took place at the European Congress on Lung Cancer in Turin between Robert Pirker who is in favor of offering
    …
    Read more
  • Next Page »
  • Sign up for AudioMedica.com news

    * = required field
    Speciality




  • Home
  • Tagged: cancer

© Copyright 2021 AudioMedica.com. Typegrid Theme by WPBandit.